[DISCLOSURE]
JW Pharmaceutical (001060) announced on Aug. 22 that it will issue redeemable convertible preferred stock worth 111.9 billion won (US$99.47 million) and offer to its largest stakeholder JW Holdings and four others, to raise capital.
JW Holdings will acquire stocks worth 68.9 billion won and increase its stake to 43.88 percent from 41.25 percent.
(
theinvestor@heraldcorp.com)
